Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT07779213 · Happitech BV

Detection of Atrial Fibrillation Using PPG From Smartphone Cameras

(FLASH AF)

What this study is about

The protocol is designed to enroll patients from at least 3 diverse clinical sites with smartphones who are being evaluated for the presence or absence of atrial fibrillation (AF) using the Heart Rhythm Software algorithm running on their smartphones. Algorithm output will be compared to a gold standard of 12-lead ECG recorded with a simultaneous PPG measurement.

View original scientific description

The protocol is designed to enroll patients from at least 3 diverse clinical sites with smartphones who are being evaluated for the presence or absence of atrial fibrillation (AF) using the Heart Rhythm Software algorithm running on their smartphones. Algorithm output will be compared to a gold standard of 12-lead ECG recorded with a simultaneous PPG measurement.

Interventions

DIAGNOSTIC_TEST

12 Lead ECG is compared to a smartphone based PPG

12 Lead ECG is compared to a smartphone based PPG

Primary outcome measures

To evaluate the sensitivity and specificity of the Heart Rhythm Software

Time frame: Through study completion, an average of 6 months

To evaluate the sensitivity and specificity of the Heart Rhythm Software algorithm running on a commercially available smartphone to detect atrial fibrillation segments using photoplethysmography (PPG) as measured through the phone's camera. Se is defined as the percentage of patients with 90 second interval recordings scored by the Heart Rhythm Software algorithm as AF, out of all intervals determined by the Clinical Adjudication Committee (CAC) to be AF (gold standard). Sp is defined as the percentage of patients with 90 second intervals scored by the Heart Rhythm Software algorithm as NSR out of all ECG recordings determined by the CAC to be NSR.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Adults aged 22 years or older
  • Owns a smartphone and knows how to operate and navigate different applications.
  • Individuals able to read, understand, and sign the consent form.
  • Cardiology patients consulting the cardiac outpatient clinic.
  • History of persistent AF or other cardiac rhythm

Exclusion criteria

  • Participants with cognitive impairments
  • Individuals who cannot read, speak, and/or understand English
  • Patients with implantable neurostimulators, cardiac implantable device in an atrial or ventricular paced rhythm documented on a 12-lead ECG during the initial study visit

Where

  • Jonesboro, Arkansas
  • Littleton, Colorado
  • New Orleans, Louisiana
  • Oklahoma City, Oklahoma

Related conditions & keywords

Atrial Fibrillation (AF)wearablessmartphone based ppgppgdigital healthhealth equityatrial fibrillationhealthtechcardiac monitoring

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Aug 21, 2026 · Source of record for eligibility and locations

📊
1 of 554 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Jonesboro

Arkansas

Location available
RECRUITING

Littleton

Colorado

Location available
NOT_YET_RECRUITING

New Orleans

Louisiana

Location available
RECRUITING

Oklahoma City

Oklahoma

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Atrial Fibrillation Trials by City

Browse all atrial fibrillation clinical trials in these cities — not just this study.

Browse More Trials by Condition

Looking for Atrial Fibrillation (AF) Treatment in Jonesboro?

Join others in Arkansas exploring innovative treatment options through clinical research

Atrial Fibrillation (AF) Treatment Options in Jonesboro, Arkansas

If you're searching for Atrial Fibrillation (AF) treatment in Jonesboro, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Jonesboro, Littleton, New Orleans and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Atrial Fibrillation (AF). All study-related care is provided at no cost to participants.

Local Sites
3 locations in Arkansas
Now Enrolling
Up to 554 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Atrial Fibrillation (AF)?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Atrial Fibrillation (AF)

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Atrial Fibrillation (AF) Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT07779213. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.